Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C447119 |
bazedoxifene acetate |
bazedoxifene acetate results in increased expression of HTR4 mRNA | increases expression | 19914376
|
D003993 |
Dibutyl Phthalate |
Dibutyl Phthalate results in increased expression of HTR4 mRNA | increases expression | 15620428
|
D005047 |
Etoposide |
HTR4 protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
C082871 |
GR 113808 |
GR 113808 binds to and results in decreased activity of HTR4 protein | affects binding|decreases activity | 15236628
|
D012701 |
Serotonin |
HTR4 protein affects the reaction [Serotonin affects the phosphorylation of PPP1R1B protein] | affects phosphorylation|affects reaction | 11880652
|
D008070 |
Lipopolysaccharides |
HTR4 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] | decreases reaction|increases secretion | 15802305
|
D008070 |
Lipopolysaccharides |
HTR4 protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL12B protein] | increases reaction|increases secretion | 15802305
|
D008070 |
Lipopolysaccharides |
HTR4 protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] | increases reaction|increases secretion | 15802305
|
D008070 |
Lipopolysaccharides |
HTR4 protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] | increases reaction|increases secretion | 15802305
|
D008070 |
Lipopolysaccharides |
HTR4 protein promotes the reaction [Lipopolysaccharides results in increased secretion of IL8 protein] | increases reaction|increases secretion | 15802305
|
C475107 |
RS 39604 |
RS 39604 binds to and results in decreased activity of HTR4 protein | affects binding|decreases activity | 15146954
|
D012643 |
Selenium |
Selenium results in increased expression of HTR4 mRNA | increases expression | 19244175
|
C105050 |
tegaserod |
tegaserod binds to and results in increased activity of HTR4 protein | affects binding|increases activity | 11560869
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of HTR4 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.72 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.10 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
4.21 | 11850527 18653653 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.50 | 17688650 |
MESH:D000855 |
Anorexia |
marker/mechanism |
|
| 15146954 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.71 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Serotonin |
2.61 | 18405062 18361446 18062943 17157402 8570775 19221690 15132762 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.61 | 20603192 17688650 18558336 18940202 15238991 18177632 18316065 19232924 17507914 17157402 18985861 19460635 18775368 18396377 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.15 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.51 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
5.43 | 14601052 |
MESH:D001919 |
Bradycardia |
|
Serotonin |
5.71 | 8112388 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
3.06 | 16322251 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Serotonin |
6.63 | 21254450 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
6.63 | 20734317 |
MESH:D021081 |
Chronobiology Disorders |
|
Serotonin |
6.96 | 17157402 |
MESH:D003092 |
Colitis |
|
Selenium |
3.99 | 17936198 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 16575769 17688650 8888407 |
MESH:D003456 |
Cryptorchidism |
|
Dibutyl Phthalate |
5.65 | 16037377 |
MESH:D003967 |
Diarrhea |
|
Serotonin |
4.96 | 8112388 11488427 10446763 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
4.15 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.15 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.23 | 1851702 |
MESH:D004487 |
Edema |
|
Serotonin |
4.64 | 18841975 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.63 | 15821434 15328337 17637181 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.37 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.18 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.01 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.74 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.51 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.30 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.47 | 14986274 19224547 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.15 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.33 | 8888407 18558336 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.17 | 9205823 11852909 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.17 | 17162251 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.55 | 16366002 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.80 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
4.02 | 17606976 18180244 16200630 16135485 15147373 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.10 | 17688650 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
2.95 | 9205823 17237260 17963957 12878042 17255318 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.46 | 16624496 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.81 | 17255318 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.06 | 16518626 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 16294345 17596541 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.93 | 15821434 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
2.26 | 12878042 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.53 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.22 | 21114838 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
4.04 | 12556972 12854902 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.86 | 15318939 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.85 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.31 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.20 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.24 | 17596541 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.23 | 16359493 8888407 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
3.32 | 19003803 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.15 | 15087411 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.79 | 11605937 12224865 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.07 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
3.99 | 17172428 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.81 | 12752131 11422049 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.84 | 10835634 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.36 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
4.90 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.85 | 17978042 3137016 16876388 1511512 11738929 11044598 15475178 14763951 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.91 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.81 | 12833885 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.33 | 15821434 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.50 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.76 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.86 | 8888407 |